QQ客服 官方微博 反馈留言

浏览/检索结果: 共26条，第1-10条 帮助 限定条件 发表日期：2020    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Large-scale Generation of Functional and Transplantable Hepatocytes and Cholangiocytes from Human Endoderm Stem Cells 期刊论文 CELL REPORTS, 2020, 卷号: 33, 期号: 10, 页码: 24 作者:  Feng, Sisi;  Wu, Jiaying;  Qiu, Wei-Lin;  Yang, Li;  Deng, Xiaogang 收藏  |  浏览/下载：38/0  |  提交时间：2021/05/24 DCZ3301, an aryl-guanidino agent, inhibits ocular neovascularization via PI3K/AKT and ERK1/2 signaling pathways 期刊论文 EXPERIMENTAL EYE RESEARCH, 2020, 卷号: 201, 页码: 8 作者:  Xu, Kai;  Li, Bo;  Zhang, Shujie;  Hu, Fangyuan;  Xu, Zhijian 收藏  |  浏览/下载：47/0  |  提交时间：2021/05/24 DCZ3301  Apoptosis  PI3K/AKT pathway  ERK1/2 pathway  Choroid microvascular sprouting  Corneal neovascularization   Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs 期刊论文 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 卷号: 117, 期号: 44, 页码: 27381-27387 作者:  Li, Zhe;  Li, Xin;  Huang, Yi-You;  Wu, Yaoxing;  Liu, Runduo 收藏  |  浏览/下载：73/0  |  提交时间：2020/12/24 virtual screening  SARS-CoV-2  drug repurposing  free energy perturbation  main protease   Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10 作者:  Zhang, Xiao-tuan;  Hu, Xiao-bei;  Wang, Han-lin;  Kan, Wei-juan;  Xu, Lei 收藏  |  浏览/下载：47/0  |  提交时间：2020/12/24 DLBCL  BTK inhibitor  ibrutinib resistance  UPR  TUDCA  2-DG   Extracellular Vesicle-Mediated Delivery of Circular RNA SCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models 期刊论文 CIRCULATION, 2020, 卷号: 142, 期号: 6, 页码: 556-574 作者:  Yang, Li;  Han, Bing;  Zhang, Zhiting;  Wang, Shuguo;  Bai, Ying 收藏  |  浏览/下载：86/0  |  提交时间：2020/12/24 circular RNA  extracellular vesicles  MeCP2 protein  neuronal plasticity  primate  stroke   Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Su, Hai-xia;  Yao, Sheng;  Zhao, Wen-feng;  Li, Min-jun;  Liu, Jia 收藏  |  浏览/下载：115/0  |  提交时间：2020/12/24 SARS-CoV-2  3CL protease  traditional Chinese medicines  Shuanghuanglian oral liquid  baicalin  baicalein   USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines 期刊论文 FEBS JOURNAL, 2020, 页码: 18 作者:  Wang, Hui;  Meng, Qian;  Ding, Yiluan;  Xiong, Muya;  Zhu, Mengying 收藏  |  浏览/下载：84/0  |  提交时间：2020/12/24 colorectal cancer  HDX-MS  inhibitor  USP25  USP28  Vismodegib   Integrative Proteomic Characterization of Human Lung Adenocarcinoma 期刊论文 CELL, 2020, 卷号: 182, 期号: 1, 页码: 245-+ 作者:  Xu, Jun-Yu;  Zhang, Chunchao;  Wang, Xiang;  Zhai, Linhui;  Ma, Yiming 收藏  |  浏览/下载：52/0  |  提交时间：2020/12/24 Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Tian, Qian-qian;  Zhu, Yun-ting;  Diao, Xing-xing;  Zhang, Xiang-lei;  Xu, Ye-chun 收藏  |  浏览/下载：68/0  |  提交时间：2020/12/24 PDE5 inhibitor  TPN729  M3  species difference  pharmacokinetics  metabolite identification   YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer 期刊论文 BRITISH JOURNAL OF CANCER, 2020, 页码: 12 作者:  Wang, Lei;  Wang, Quanren;  Xu, Piaopiao;  Fu, Li;  Li, Yun 收藏  |  浏览/下载：15/0  |  提交时间：2020/12/24